Tegretol and Ataxia aggravated - a phase IV clinical study of FDA data
Ataxia aggravated is found among people who take Tegretol, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Tegretol and have Ataxia aggravated. It is created by eHealthMe based on reports of 41,962 people who have side effects when taking Tegretol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
41,962 people reported to have side effects when taking Tegretol.
Among them, 349 people (0.83%) have Ataxia aggravated.
What is Tegretol?
Tegretol has active ingredients of carbamazepine. It is often used in epilepsy. eHealthMe is studying from 42,341 Tegretol users for its effectiveness, alternative drugs and more.
What is Ataxia aggravated?
Ataxia aggravated (serious loss of full control of bodily movements) is found to be associated with 761 drugs and 313 conditions by eHealthMe.
Number of Tegretol and Ataxia aggravated reports submitted per year:
Time on Tegretol when people have Ataxia aggravated *:
Gender of people who have Ataxia aggravated when taking Tegretol*:
Age of people who have Ataxia aggravated when taking Tegretol *:
Common drugs people take besides Tegretol *:
Common side effects people have besides Ataxia aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Tegretol and have Ataxia aggravated?Check whether Ataxia aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Puvanendran R, Teo HZ, "Case report of use of Black Cohosh for carbamazepine induced hot flushes in a post menopausal woman", Maturitas, 2017 Jun .
- Arshad F, Ladakhi Y, Khan MA, "A rare case of carbamazepine induced pancreatitis", International Journal of Students’ Research, 2013 Jul .
- Yava?o?lu I, Sarg?n G, Demirbulat A, "Carbamazepine and hematological malignancies", Turkish journal of haematology: official journal of Turkish Society of Haematology, 2013 Jan .
How severe was Ataxia aggravated and when was it recovered:
Expand to all the drugs that have ingredients of carbamazepine:
Alternative drugs to, pros and cons of Tegretol:
- Tegretol (42,341 reports)
Common Tegretol side effects:
Browse all side effects of Tegretol:a b c d e f g h i j k l m n o p q r s t u v w x y z
Ataxia aggravated treatments and more:
- Ataxia aggravated (6 reports)
COVID vaccines that are related to Ataxia aggravated:
- Ataxia aggravated in Moderna COVID Vaccine
- Ataxia aggravated in Pfizer BioNTech Covid Vaccine
- Ataxia aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Ataxia aggravated:
All the drugs that are associated with Ataxia aggravated:
- Ataxia aggravated (761 drugs)
Common conditions associated with Ataxia aggravated:
All the conditions that are associated with Ataxia aggravated:
- Ataxia aggravated (313 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on carbamazepine (the active ingredients of Tegretol) and Tegretol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Levaquin and Extrapyramidal Disorder - 5 seconds ago
- Lioresal and Drug Effect Decreased - 8 seconds ago
- Lidocaine and Vein Discoloration - 11 seconds ago
- Levoxyl and Phenytek drug interaction - 17 seconds ago
- Crohn'S Disease and Dysuria Aggravated - 22 seconds ago
- Lenvima and Tremor - 27 seconds ago
- Peg-Intron and Colonic Polyp - 29 seconds ago
- Wellbutrin and Gastrointestinal Motility Disorder - 34 seconds ago
- Gastritis Aggravated and Motor Neurone Disease - 34 seconds ago
- Suicide Attempt and Cardiogenic Shock - 35 seconds ago